CHS Inc (NASDAQ:CHSCP) is expected to pay $0.50 on Mar 30, 2018. $2.00 is the ADY. (NASDAQ:CHSCP) shareholders before Mar 15, 2018 will receive the $0.50 dividend. CHS Inc’s current price of $30.32 translates into 1.65% yield. CHS Inc’s dividend has Mar 16, 2018 as record date. Jan 9, 2018 is the announcement. The stock increased 0.70% or $0.2099 during the last trading session, reaching $30.3199. About 21,659 shares traded or 64.39% up from the average. CHS Inc. (NASDAQ:CHSCP) has declined 4.91% since March 14, 2017 and is downtrending. It has underperformed by 21.61% the S&P500.
Kewaunee Scientific Corporation designs, makes, and installs laboratory, healthcare, and technical furniture products. The company has market cap of $81.04 million. The firm operates in two divisions, Domestic and International. It has a 16 P/E ratio. The Company’s products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
The stock increased 0.72% or $0.2112 during the last trading session, reaching $29.7412. About 19,517 shares traded or 474.37% up from the average. Kewaunee Scientific Corporation (KEQU) has risen 38.94% since March 14, 2017 and is uptrending. It has outperformed by 22.24% the S&P500.
Since January 1, 0001, it had 1 insider purchase, and 0 selling transactions for $57,581 activity.
Perritt Capital Management Inc holds 0.39% of its portfolio in Kewaunee Scientific Corporation for 49,869 shares. North Star Investment Management Corp. owns 82,625 shares or 0.31% of their US portfolio. Moreover, Salem Investment Counselors Inc has 0.19% invested in the company for 54,625 shares. The Wisconsin-based Morgan Dempsey Capital Management Llc has invested 0.13% in the stock. Carroll Financial Associates Inc., a North Carolina-based fund reported 4,800 shares.
Investors sentiment decreased to 0 in 2017 Q3. Its down 1.00, from 1 in 2017Q2. It is negative, as 0 investors sold CHS Inc. shares while 1 reduced holdings. 1 funds opened positions while 0 raised stakes. 52,607 shares or 21.33% more from 43,357 shares in 2017Q2 were reported. Benchmark Advisors invested 0.91% of its portfolio in CHS Inc. (NASDAQ:CHSCP). Fny Managed Accounts Lc has invested 0.51% in CHS Inc. (NASDAQ:CHSCP).